Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile

Bioorganic & Medicinal Chemistry Letters
2002.0

Abstract

The COX-2 inhibitor DFP [5,5-dimethyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2(5H)-furanone] was found to have a long half-life in humans. Analogues have been characterized in order to optimize pharmacokinetics. This has lead to the discovery of 5(S)-(5-ethyl-5-methyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2(5H)-furanone analogue 11 a potent and selective COX-2 inhibitor which is metabolized to a greater extent than DFP upon incubation with rat and human hepatocytes, suggesting a shorter half-life in humans.

Knowledge Graph

Similar Paper

Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile
Bioorganic & Medicinal Chemistry Letters 2002.0
SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor
Bioorganic & Medicinal Chemistry Letters 1999.0
A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 1999.0
A prodrug approach to COX-2 inhibitors with methylsulfone
Bioorganic & Medicinal Chemistry Letters 2004.0
2,2-Dimethyl-4,5-diaryl-3(2 H )furanone derivatives as selective cyclo-oxygenase-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 2001.0
6-Alkyl, alkoxy, or alkylthio-substituted 3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 2003.0
The novel benzopyran class of selective cyclooxygenase-2 inhibitors-part I: The first clinical candidate
Bioorganic & Medicinal Chemistry Letters 2010.0
In Vitro Structure−Activity Relationship and in Vivo Studies for a Novel Class of Cyclooxygenase-2 Inhibitors:  5-Aryl-2,2-dialkyl-4-phenyl-3(2H)furanone Derivatives
Journal of Medicinal Chemistry 2004.0
Synthesis and biological evaluation of 3-heteroaryloxy-4-phenyl-2(5H)-furanones as selective COX-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 1999.0
Cyclooxygenase-2 Inhibitors. Synthesis and Pharmacological Activities of 5-Methanesulfonamido-1-indanone Derivatives
Journal of Medicinal Chemistry 1995.0